allogenic adipose-derived mesenchymal stem cell therapy (Mayo Clinic)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameallogenic adipose-derived mesenchymal stem cell therapy (Mayo Clinic)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMayo Clinic

China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A